BioNTech SE Files 2024 Annual Report
Ticker: BNTX · Form: 20-F · Filed: Mar 10, 2025 · CIK: 1776985
| Field | Detail |
|---|---|
| Company | Biontech Se (BNTX) |
| Form Type | 20-F |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, biotechnology, financials
TL;DR
BioNTech dropped its 2024 20-F, check it for the latest on their financials and biz.
AI Summary
BioNTech SE filed its 20-F annual report for the fiscal year ending December 31, 2024. The report details the company's financial performance and business operations, including its significant role in vaccine development. Key financial figures and operational highlights for 2024 are presented within the filing.
Why It Matters
This filing provides investors and the public with a comprehensive overview of BioNTech's financial health and strategic direction for the past fiscal year, crucial for understanding its ongoing contributions to biotechnology.
Risk Assessment
Risk Level: medium — As a biotechnology company, BioNTech faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 20-F filing.
Key Numbers
- 2024 — Fiscal Year (The period covered by the annual report)
- 1231 — Fiscal Year End (Indicates the end of the reporting period)
Key Players & Entities
- BioNTech SE (company) — Filer of the 20-F report
- 2024-12-31 (date) — Fiscal year end date
- 2025-03-10 (date) — Filing date
- Mainz (location) — Company headquarters city
FAQ
What is the primary business of BioNTech SE?
BioNTech SE is primarily involved in the development of biological products, specifically vaccines and immunotherapies, as indicated by its SIC code 2836.
What is the filing date of this 20-F report?
This 20-F report was filed as of March 10, 2025.
What is the fiscal year end for BioNTech SE?
BioNTech SE's fiscal year ends on December 31st.
Where is BioNTech SE headquartered?
BioNTech SE is headquartered in Mainz, Germany.
What is the SEC file number for BioNTech SE?
The SEC file number for BioNTech SE is 001-39081.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 10, 2025 regarding BioNTech SE (BNTX).